How do the macrocyclic lactones kill filarial nematode larvae?

Area of Science:

• Parasitology
• Pharmacology
• Veterinary Medicine

Background:

• Macrocyclic lactones (MLs) are vital drugs for controlling human filarial infections (onchocerciasis, lymphatic filariasis) and preventing heartworm in pets.
• The exact mechanism of action for MLs against these parasitic nematodes is not fully understood.
• A significant gap exists between drug concentrations achieved in plasma and those needed to paralyze worms in vitro.

Purpose of the Study:

• To investigate the mechanism of action of macrocyclic lactones (MLs) against filarial parasites.
• To explore the role of glutamate-gated chloride channels as the ML target in nematodes.
• To elucidate the contribution of the host immune system to the efficacy of ML treatment.

Main Methods:

• In vitro measurements of nematode motility.
• Analysis of drug concentrations in plasma post-administration.
• Review of recent evidence on ML target function and host-parasite interactions.

Main Results:

• Observed a large discrepancy between in vivo plasma concentrations and in vitro effective concentrations for MLs.
• Identified glutamate-gated chloride channels as the likely target of MLs in filarial nematodes.
• New evidence supports the hypothesis that the host immune system aids in the rapid clearance of microfilariae after ML treatment.

Conclusions:

• The efficacy of macrocyclic lactones in treating filarial infections may depend on more than direct parasite paralysis.
• Glutamate-gated chloride channels are confirmed as key targets for MLs in filarial nematodes.
• The host immune system plays a significant role in the clearance of microfilariae following macrocyclic lactone therapy.